Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TNFSF12-TNFSF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MYH14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WDR55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFSF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JADE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC38A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM46A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF350 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928464 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
E2F6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMTA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on